Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling and simulation software for the pharmaceutical and biotechnology, generics, chemical, cosmetic, and food ingredient industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research and development costs and helping clients make better project decisions sooner. Founded in 1996, Simulations Plus employs over 60 employees and is publicly traded on the NASDAQ stock exchange (ticker symbol = SLP). Our headquarters are based in Lancaster, California, with our pharmacometrics consulting team located in Buffalo, New York. Trusted distributors handle sales and scientific support in Asian territories. Nineteen of the top twenty pharmaceutical companies, plus numerous mid- and small-sized companies and all major regulatory agencies, license our modeling and simulation technology.